Norepinephrine for Spinal-induced Hypotension

Spinal Anesthesia Clinical Trial

— NE in spianl  

Official title:

Prophylactic Norepinephrine Infusion for Spinal-induced Hypotension

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03308708
• Other study ID #: NE_spinal
• Status: Not yet recruiting
• Phase: N/A
• First received: October 9, 2017
• Last updated: October 9, 2017
• Start date: November 1, 2017
• Est. completion date: January 1, 2018

Study information

• Verified date: October 2017
• Source: Mansoura University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Norepinephrine (NE) infusion is used prophylactically to counteract the vasodilator effect of spinal anesthesia. prophylactic use of NE infusion is expected to decrease bouts of hypotension, vomiting and increase patient satisfaction

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 50
• Est. completion date: January 1, 2018
• Est. primary completion date: January 1, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• All patients scheduled for elective surgery under spinal anesthesia

Exclusion Criteria:

• ischemic heart disease uncontrolled hypertension

Related Conditions & MeSH terms

• Hypotension
• Spinal Anesthesia

Intervention

Drug:
• Norepinephrine infusion
Norepinephrine infusion (5miclml) is immediately started after spinal anesthesia. Rate starts at 30 ml/h and modified according to hemodynamic state

Locations

Country	Name	City	State
Egypt	Mansoura university	Al Mansurah	Dkahleya

Sponsors (1)

Lead Sponsor	Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	incidence of hypotension	intraoperative decrease of patient blood pressure by more than 20% from its basal reading	intraoperative